BDX - Becton Dickinson reports Q2 results raises guidance
2024-05-02 06:33:15 ET
| Fiscal 2024 Guidanceas of May 2, 2024 |
| Fiscal 2024 Guidanceas of Feb 1, 2024 |
| Total Revenues |
| ~$20.1 to $20.3 billion |
| ~$20.2 to $20.4 billion |
| Organic Revenue Growth ( FXN ) |
| 5.5% to 6.25% |
| 5.5% to 6.25% |
| Impact of Surgical Instrumentation Platform Divestiture |
| (~75) basis points |
| (~75) basis points |
| Revenue Growth ( FXN ) |
| 4.75% to 5.5% |
| 4.75% to 5.5% |
| Estimated Foreign Currency Impact to Revenue Growth |
| (~65) basis points |
| (~25) basis points |
| Adjusted Diluted EPS |
| $12.95 to $13.15 |
| $12.82 to $13.06 |
| Adjusted Diluted EPS Growth |
| 6.1% to 7.7% |
| ~5% to 7% |
| Estimated Impact of Surgical Instrumentation PlatformDivestiture included in Adjusted Diluted EPS |
| (~75) basis points |
| (~75) basis points |
| Estimated Foreign Currency Impact included in AdjustedDiluted EPS |
| (~425) basis points |
| (~360) basis points |